Thyroid nodules are present in up to 50 percent of adults in the fifth decade of life. Patients are often treated with thyroxine in order to reduce the size of the nodule, but the efficacy of thyrotropin-suppressive therapy with thyroxine remains uncertain. In this study, 53 patients with a colloid solitary thyroid nodule confirmed by biopsy were randomly assigned in a double-blind manner to receive placebo (n = 25) or levothyroxine (n = 28) for six months. Before treatment, pertechnetate-99m thyroid scanning showed that 22 percent of the nodules were functional, 25 percent hypofunctional, and 53 percent nonfunctional. High-resolution (10-MHz) sonography was used to measure the size of the nodules before and after treatment. Suppression of thyrotropin release was confirmed in the levothyroxine-treated group by the administration of thyrotropin-releasing hormone; thyrotropin release was normal in the placebo group. Six months of therapy did not significantly decrease the diameter or volume of the nodules in the levothyroxine group as compared with the placebo group. We conclude that the efficacy of levothyroxine therapy in reducing the size of colloid thyroid nodules is not apparent within six months, despite effective suppression of thyrotropin.
This article has been cited by other articles:
Castro, M. R., Gharib, H.
(2005). Continuing Controversies in the Management of Thyroid Nodules. ANN INTERN MED
142: 926-931
[Abstract][Full Text]
Krohn, K., Fuhrer, D., Bayer, Y., Eszlinger, M., Brauer, V., Neumann, S., Paschke, R.
(2005). Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter. Endocr. Rev.
26: 504-524
[Abstract][Full Text]
Mandel, S. J.
(2004). A 64-Year-Old Woman With a Thyroid Nodule. JAMA
292: 2632-2642
[Full Text]
Brenta, G., Schnitman, M., Fretes, O., Facco, E., Gurfinkel, M., Damilano, S., Pacenza, N., Blanco, A., Gonzalez, E., Pisarev, M. A.
(2003). Comparative Efficacy and Side Effects of the Treatment of Euthyroid Goiter with Levo-Thyroxine or Triiodothyroacetic Acid. J. Clin. Endocrinol. Metab.
88: 5287-5292
[Abstract][Full Text]
Alexander, E. K., Hurwitz, S., Heering, J. P., Benson, C. B., Frates, M. C., Doubilet, P. M., Cibas, E. S., Larsen, P R., Marqusee, E.
(2003). Natural History of Benign Solid and Cystic Thyroid Nodules. ANN INTERN MED
138: 315-318
[Abstract][Full Text]
Wemeau, J.-L., Caron, P., Schvartz, C., Schlienger, J.-L., Orgiazzi, J., Cousty, C., Vlaeminck-Guillem, V.
(2002). Effects of Thyroid-Stimulating Hormone Suppression with Levothyroxine in Reducing the Volume of Solitary Thyroid Nodules and Improving Extranodular Nonpalpable Changes: A Randomized, Double-Blind, Placebo-Controlled Trial by the French Thyroid Research Group. J. Clin. Endocrinol. Metab.
87: 4928-4934
[Abstract][Full Text]
Castro, M. R., Caraballo, P. J., Morris, J. C.
(2002). Effectiveness of Thyroid Hormone Suppressive Therapy in Benign Solitary Thyroid Nodules: A Meta-Analysis. J. Clin. Endocrinol. Metab.
87: 4154-4159
[Abstract][Full Text]
Krohn, K., Paschke, R.
(2001). Progress in Understanding the Etiology of Thyroid Autonomy. J. Clin. Endocrinol. Metab.
86: 3336-3345
[Full Text]
Brander, A. E. E., Viikinkoski, V. P., Nickels, J. I., Kivisaari, L. M.
(2000). Importance of Thyroid Abnormalities Detected at US Screening: A 5-year Follow-up. Radiology
215: 801-806
[Abstract][Full Text]
(1999). Changes in Thyroid Nodule Volume Caused by Fine-Needle Aspiration: A Factor Complicating the Interpretation of the Effect of Thyrotropin Suppression on Nodule Size. J. Clin. Endocrinol. Metab.
84: 4566-4569
[Abstract][Full Text]
Zelmanovitz, F., Genro, S., Gross, J. L.
(1998). Suppressive Therapy with Levothyroxine for Solitary Thyroid Nodules: A Double-blind Controlled Clinical Study and Cumulative Meta-analyses. J. Clin. Endocrinol. Metab.
83: 3881-3885
[Abstract][Full Text]
Hermus, A. R., Huysmans, D. A.
(1998). Treatment of Benign Nodular Thyroid Disease. NEJM
338: 1438-1447
[Full Text]
Papini, E., Petrucci, L., Guglielmi, R., Panunzi, C., Rinaldi, R., Bacci, V., Crescenzi, A., Nardi, F., Fabbrini, R., Pacella, C. M.
(1998). Long-Term Changes in Nodular Goiter: A 5-Year Prospective Randomized Trial of Levothyroxine Suppressive Therapy for Benign Cold Thyroid Nodules. J. Clin. Endocrinol. Metab.
83: 780-783
[Abstract][Full Text]
Bennedbæk, F. N., Nielsen, L. K., Hegedüs, L.
(1998). Effect of Percutaneous Ethanol Injection Therapy Versus Suppressive Doses of L-Thyroxine on Benign Solitary Solid Cold Thyroid Nodules: A Randomized Trial. J. Clin. Endocrinol. Metab.
83: 830-835
[Abstract][Full Text]
Peran, S., Garriga, M. J., Morreale de Escobar, G., Asuncion, M., Peran, M.
(1997). Increase in Plasma Thyrotropin Levels in Hypothyroid Patients during Treatment due to a Defect in the Commercial Preparation. J. Clin. Endocrinol. Metab.
82: 3192-3195
[Abstract][Full Text]
Petrone, L. R.
(1996). A Primary Care Approach to the Adult Patient With Nodular Thyroid Disease. Arch Fam Med
5: 92-100
[Abstract]
Tan, G. H., Gharib, H., Reading, C. C.
(1995). Solitary Thyroid Nodule: Comparison Between Palpation and Ultrasonography. Arch Intern Med
155: 2418-2423
[Abstract]
Cooper, D. S.
(1994). Thyroid Hormone, Osteoporosis, and Estrogen. JAMA
271: 1283-1284
[Abstract]
Mazzaferri, E. L.
(1993). Management of a Solitary Thyroid Nodule. NEJM
328: 553-559
[Full Text]
Sanders, L. E., Rossi, R. L., Shahian, D. M., Williamson, W. A.
(1992). Mediastinal Goiters: The Need for an Aggressive Approach. Arch Surg
127: 609-613
[Abstract]
Robbins, J., Merino, M. J., Boice, J. D. Jr., Ron, E., Ain, K. B., Alexander, H. R., Norton, J. A., Reynolds, J.
(1991). Thyroid Cancer: A Lethal Endocrine Neoplasm. ANN INTERN MED
115: 133-147
[Abstract]
Hegedus, L., Hansen, J. M., Karstrup, S., Torp-Pedersen, S., Juul, N.
(1988). Tetracycline for Sclerosis of Thyroid Cysts: A Randomized Study. Arch Intern Med
148: 1116-1118
[Abstract]
(1987). THYROXINE DOES NOT SHRINK THYROID NODULES. JWatch General
1987: 38-38
[Full Text]
Previous
